Brilinta War: AstraZeneca, Dr Reddys in patent battle over generic version of ticagrelor Ruby Khatun Khatun27 July 2018 3:31 PM ISTNew Delhi: Dr Reddy's Laboratories has been dragged to Delhi High Court by AstraZeneca in order to block the firm from launching the generic versions...
Zydus Cadila gets USFDA nod for blood pressure treatment drug Ruby Khatun Khatun30 Nov 2017 10:45 AM ISTNew Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
Abbott pulls back its bioresorbable stent-ABSORB, also moves to withdraw XIENCE from India Ruby Khatun Khatun11 Sept 2017 3:17 PM ISTNew Delhi: Abbott has taken up the decision to stop the sales of sales of its bioresorbable coronary stent 'Absorb' globally due to low commercial...
Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...